US 11530259
Therapies and methods to treat TLR2-mediated diseases and disorders
granted A61KA61K2039/505A61K31/60
Quick answer
US patent 11530259 (Therapies and methods to treat TLR2-mediated diseases and disorders) held by The Regents of the University of California expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K31/60, A61K39/39516, A61K39/39533